$NEO Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in NEOGENOMICS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in NEOGENOMICS INC. Get notifications about new insider transactions in NEOGENOMICS INC for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 14 2021 | NEO | NEOGENOMICS INC | TETRAULT LYNN A. | Director | Option Exercise | M | 9.11 | 1,389 | 12,654 | 0 | |
Jun 14 2021 | NEO | NEOGENOMICS INC | TETRAULT LYNN A. | Director | Buy | M | 9.11 | 1,389 | 12,654 | 34,939 | 33.6 K to 34.9 K (+4.14 %) |
Jun 04 2021 | NEO | NEOGENOMICS INC | CROWTHER BRUCE K | Director | Option Exercise | A | 40.90 | 3,714 | 151,903 | 3,714 | |
Jun 04 2021 | NEO | NEOGENOMICS INC | CROWTHER BRUCE K | Director | Grant | A | 0.00 | 3,081 | 0 | 49,564 | 46.5 K to 49.6 K (+6.63 %) |
Jun 04 2021 | NEO | NEOGENOMICS INC | KANOVSKY STEPHEN M | Director | Option Exercise | A | 40.90 | 3,714 | 151,903 | 3,714 | |
Jun 04 2021 | NEO | NEOGENOMICS INC | KANOVSKY STEPHEN M | Director | Grant | A | 0.00 | 3,081 | 0 | 9,198 | 6.1 K to 9.2 K (+50.37 %) |
Jun 04 2021 | NEO | NEOGENOMICS INC | CARDOZA GEORGE | President, Pharma S ... | Sell | S | 40.11 | 31,107 | 1,247,702 | 176,772 | 207.9 K to 176.8 K (-14.96 %) |
Jun 04 2021 | NEO | NEOGENOMICS INC | CARDOZA GEORGE | President, Pharma S ... | Sell | S | 40.39 | 169,230 | 6,835,200 | 207,879 | 377.1 K to 207.9 K (-44.88 %) |
Apr 26 2021 | NEO | NEOGENOMICS INC | Weiss Lawrence Martin | Chief Medical Offic ... | Option Exercise | M | 28.33 | 9,378 | 265,679 | 28,136 | |
Apr 26 2021 | NEO | NEOGENOMICS INC | Weiss Lawrence Martin | Chief Medical Offic ... | Option Exercise | M | 19.60 | 9,005 | 176,498 | 18,012 | |
Apr 26 2021 | NEO | NEOGENOMICS INC | Weiss Lawrence Martin | Chief Medical Offic ... | Option Exercise | M | 9.22 | 6,667 | 61,470 | 0 | |
Apr 26 2021 | NEO | NEOGENOMICS INC | Weiss Lawrence Martin | Chief Medical Offic ... | Buy | M | 28.33 | 9,378 | 265,679 | 130,847 | 121.5 K to 130.8 K (+7.72 %) |
Apr 26 2021 | NEO | NEOGENOMICS INC | Weiss Lawrence Martin | Chief Medical Offic ... | Buy | M | 19.60 | 9,005 | 176,498 | 121,469 | 112.5 K to 121.5 K (+8.01 %) |
Apr 26 2021 | NEO | NEOGENOMICS INC | Weiss Lawrence Martin | Chief Medical Offic ... | Buy | M | 9.22 | 6,667 | 61,470 | 112,464 | 105.8 K to 112.5 K (+6.30 %) |
Apr 21 2021 | NEO | NEOGENOMICS INC | Mallon Mark | Chief Executive Off ... | Option Exercise | A | 49.34 | 151,016 | 7,451,129 | 151,016 | |
Apr 21 2021 | NEO | NEOGENOMICS INC | Mallon Mark | Chief Executive Off ... | Grant | A | 0.00 | 55,736 | 0 | 55,736 | 0 to 55.7 K |
Mar 04 2021 | NEO | NEOGENOMICS INC | Brown Douglas Matthew | Chief Strategy Offi ... | Option Exercise | A | 53.17 | 26,378 | 1,402,518 | 26,378 | |
Mar 04 2021 | NEO | NEOGENOMICS INC | Brown Douglas Matthew | Chief Strategy Offi ... | Grant | A | 0.00 | 4,655 | 0 | 111,644 | 107 K to 111.6 K (+4.35 %) |
Mar 03 2021 | NEO | NEOGENOMICS INC | McKenzie Kathryn B | Chief Financial Off ... | Option Exercise | A | 53.17 | 35,171 | 1,870,042 | 35,171 | |
Mar 03 2021 | NEO | NEOGENOMICS INC | McKenzie Kathryn B | Chief Financial Off ... | Grant | A | 0.00 | 6,207 | 0 | 13,535 | 7.3 K to 13.5 K (+84.70 %) |
Mar 03 2021 | NEO | NEOGENOMICS INC | McKenzie Kathryn B | Chief Financial Off ... | Payment of Exercise | F | 0.00 | 432 | 0 | 7,328 | 7.8 K to 7.3 K (-5.57 %) |
Mar 03 2021 | NEO | NEOGENOMICS INC | McKenzie Kathryn B | Chief Financial Off ... | Payment of Exercise | F | 0.00 | 169 | 0 | 7,760 | 7.9 K to 7.8 K (-2.13 %) |
Mar 03 2021 | NEO | NEOGENOMICS INC | VAN OORT DOUGLAS M | Chairman and CEO | Grant | A | 0.00 | 56,423 | 0 | 2,474,716 | 2.4 M to 2.5 M (+2.33 %) |
Mar 03 2021 | NEO | NEOGENOMICS INC | VAN OORT DOUGLAS M | Chairman and CEO | Payment of Exercise | F | 0.00 | 2,158 | 0 | 2,418,293 | 2.4 M to 2.4 M (-0.09 %) |
Mar 03 2021 | NEO | NEOGENOMICS INC | VAN OORT DOUGLAS M | Chairman and CEO | Payment of Exercise | F | 0.00 | 2,339 | 0 | 2,420,451 | 2.4 M to 2.4 M (-0.10 %) |
Mar 03 2021 | NEO | NEOGENOMICS INC | Bonello William | President, Informat ... | Option Exercise | A | 53.17 | 24,619 | 1,308,992 | 24,619 | |
Mar 03 2021 | NEO | NEOGENOMICS INC | Bonello William | President, Informat ... | Grant | A | 0.00 | 4,345 | 0 | 15,473 | 11.1 K to 15.5 K (+39.05 %) |
Mar 03 2021 | NEO | NEOGENOMICS INC | Bonello William | President, Informat ... | Payment of Exercise | F | 0.00 | 432 | 0 | 11,128 | 11.6 K to 11.1 K (-3.74 %) |
Mar 03 2021 | NEO | NEOGENOMICS INC | Bonello William | President, Informat ... | Payment of Exercise | F | 0.00 | 500 | 0 | 11,560 | 12.1 K to 11.6 K (-4.15 %) |
Mar 03 2021 | NEO | NEOGENOMICS INC | BALLIET JENNIFER | VP and Chief Cultur ... | Option Exercise | A | 53.17 | 10,551 | 560,997 | 10,551 | |
Mar 03 2021 | NEO | NEOGENOMICS INC | BALLIET JENNIFER | VP and Chief Cultur ... | Grant | A | 0.00 | 1,862 | 0 | 26,457 | 24.6 K to 26.5 K (+7.57 %) |
Mar 03 2021 | NEO | NEOGENOMICS INC | BALLIET JENNIFER | VP and Chief Cultur ... | Payment of Exercise | F | 0.00 | 173 | 0 | 24,595 | 24.8 K to 24.6 K (-0.70 %) |
Mar 03 2021 | NEO | NEOGENOMICS INC | BALLIET JENNIFER | VP and Chief Cultur ... | Payment of Exercise | F | 0.00 | 212 | 0 | 24,768 | 25 K to 24.8 K (-0.85 %) |
Mar 03 2021 | NEO | NEOGENOMICS INC | Pedulla Denise E | General Counsel | Option Exercise | A | 53.17 | 24,619 | 1,308,992 | 24,619 | |
Mar 03 2021 | NEO | NEOGENOMICS INC | Pedulla Denise E | General Counsel | Grant | A | 0.00 | 4,345 | 0 | 60,643 | 56.3 K to 60.6 K (+7.72 %) |
Mar 03 2021 | NEO | NEOGENOMICS INC | Pedulla Denise E | General Counsel | Payment of Exercise | F | 0.00 | 216 | 0 | 56,298 | 56.5 K to 56.3 K (-0.38 %) |
Mar 03 2021 | NEO | NEOGENOMICS INC | Pedulla Denise E | General Counsel | Payment of Exercise | F | 0.00 | 212 | 0 | 56,514 | 56.7 K to 56.5 K (-0.37 %) |
Mar 03 2021 | NEO | NEOGENOMICS INC | SHOVLIN ROBERT J. | President, Clinical ... | Option Exercise | A | 53.17 | 38,688 | 2,057,041 | 38,688 | |
Mar 03 2021 | NEO | NEOGENOMICS INC | SHOVLIN ROBERT J. | President, Clinical ... | Grant | A | 0.00 | 6,827 | 0 | 153,747 | 146.9 K to 153.7 K (+4.65 %) |
Mar 03 2021 | NEO | NEOGENOMICS INC | SHOVLIN ROBERT J. | President, Clinical ... | Payment of Exercise | F | 0.00 | 608 | 0 | 146,920 | 147.5 K to 146.9 K (-0.41 %) |
Mar 03 2021 | NEO | NEOGENOMICS INC | SHOVLIN ROBERT J. | President, Clinical ... | Payment of Exercise | F | 0.00 | 742 | 0 | 147,528 | 148.3 K to 147.5 K (-0.50 %) |
Mar 03 2021 | NEO | NEOGENOMICS INC | Dieter Cynthia J | Chief Accounting Of ... | Option Exercise | A | 53.17 | 7,034 | 373,998 | 7,034 | |
Mar 03 2021 | NEO | NEOGENOMICS INC | Dieter Cynthia J | Chief Accounting Of ... | Grant | A | 0.00 | 1,241 | 0 | 1,846 | 605 to 1.8 K (+205.12 %) |
Mar 03 2021 | NEO | NEOGENOMICS INC | CARDOZA GEORGE | President, Pharma S ... | Option Exercise | A | 53.17 | 35,171 | 1,870,042 | 35,171 | |
Mar 03 2021 | NEO | NEOGENOMICS INC | CARDOZA GEORGE | President, Pharma S ... | Grant | A | 0.00 | 6,207 | 0 | 377,109 | 370.9 K to 377.1 K (+1.67 %) |
Mar 03 2021 | NEO | NEOGENOMICS INC | Weiss Lawrence Martin | Chief Medical Offic ... | Option Exercise | A | 53.17 | 29,895 | 1,589,517 | 29,895 | |
Mar 03 2021 | NEO | NEOGENOMICS INC | Weiss Lawrence Martin | Chief Medical Offic ... | Grant | A | 0.00 | 5,276 | 0 | 105,797 | 100.5 K to 105.8 K (+5.25 %) |
Jan 11 2021 | NEO | NEOGENOMICS INC | JONES STEVEN C | Director | Option Exercise | M | 22.52 | 4,269 | 96,138 | 0 | |
Jan 11 2021 | NEO | NEOGENOMICS INC | JONES STEVEN C | Director | Option Exercise | M | 11.60 | 3,017 | 34,997 | 0 | |
Jan 11 2021 | NEO | NEOGENOMICS INC | JONES STEVEN C | Director | Option Exercise | M | 7.27 | 10,000 | 72,700 | 0 | |
Jan 11 2021 | NEO | NEOGENOMICS INC | JONES STEVEN C | Director | Option Exercise | M | 7.15 | 100,000 | 715,000 | 0 | |
Jan 11 2021 | NEO | NEOGENOMICS INC | JONES STEVEN C | Director | Buy | M | 22.52 | 4,269 | 96,138 | 90,218 | 85.9 K to 90.2 K (+4.97 %) |
Jan 11 2021 | NEO | NEOGENOMICS INC | JONES STEVEN C | Director | Buy | M | 11.60 | 3,017 | 34,997 | 85,949 | 82.9 K to 85.9 K (+3.64 %) |
Jan 11 2021 | NEO | NEOGENOMICS INC | JONES STEVEN C | Director | Buy | M | 7.27 | 10,000 | 72,700 | 82,932 | 72.9 K to 82.9 K (+13.71 %) |
Jan 11 2021 | NEO | NEOGENOMICS INC | JONES STEVEN C | Director | Buy | M | 7.15 | 100,000 | 715,000 | 1,100,000 | 1000 K to 1.1 M (+10.00 %) |
Dec 15 2020 | NEO | NEOGENOMICS INC | Weiss Lawrence Martin | Chief Medical Offic ... | Option Exercise | M | 19.60 | 9,005 | 176,498 | 27,017 | |
Dec 15 2020 | NEO | NEOGENOMICS INC | Weiss Lawrence Martin | Chief Medical Offic ... | Option Exercise | M | 13.87 | 16,666 | 231,157 | 8,334 | |
Dec 15 2020 | NEO | NEOGENOMICS INC | Weiss Lawrence Martin | Chief Medical Offic ... | Option Exercise | M | 9.22 | 13,333 | 122,930 | 6,667 | |
Dec 15 2020 | NEO | NEOGENOMICS INC | Weiss Lawrence Martin | Chief Medical Offic ... | Option Exercise | M | 7.27 | 20,000 | 145,400 | 0 | |
Dec 15 2020 | NEO | NEOGENOMICS INC | Weiss Lawrence Martin | Chief Medical Offic ... | Option Exercise | M | 6.98 | 50,000 | 349,000 | 0 | |
Dec 15 2020 | NEO | NEOGENOMICS INC | Weiss Lawrence Martin | Chief Medical Offic ... | Sell | S | 51.06 | 20,200 | 1,031,412 | 100,521 | 120.7 K to 100.5 K (-16.73 %) |
Dec 15 2020 | NEO | NEOGENOMICS INC | Weiss Lawrence Martin | Chief Medical Offic ... | Buy | M | 19.60 | 9,005 | 176,498 | 120,721 | 111.7 K to 120.7 K (+8.06 %) |
Dec 15 2020 | NEO | NEOGENOMICS INC | Weiss Lawrence Martin | Chief Medical Offic ... | Buy | M | 13.87 | 16,666 | 231,157 | 111,716 | 95.1 K to 111.7 K (+17.53 %) |
Dec 15 2020 | NEO | NEOGENOMICS INC | Weiss Lawrence Martin | Chief Medical Offic ... | Buy | M | 9.22 | 13,333 | 122,930 | 95,050 | 81.7 K to 95.1 K (+16.32 %) |
Dec 15 2020 | NEO | NEOGENOMICS INC | Weiss Lawrence Martin | Chief Medical Offic ... | Buy | M | 7.27 | 20,000 | 145,400 | 81,717 | 61.7 K to 81.7 K (+32.41 %) |
Dec 15 2020 | NEO | NEOGENOMICS INC | Weiss Lawrence Martin | Chief Medical Offic ... | Buy | M | 6.98 | 50,000 | 349,000 | 61,717 | 11.7 K to 61.7 K (+426.73 %) |
Dec 14 2020 | NEO | NEOGENOMICS INC | JONES STEVEN C | Director | Sell | S | 51.67 | 25,000 | 1,291,750 | 1,000,000 | 1 M to 1000 K (-2.44 %) |
Dec 14 2020 | NEO | NEOGENOMICS INC | JONES STEVEN C | Director | Sell | S | 50.52 | 25,000 | 1,263,000 | 1,025,000 | 1.1 M to 1 M (-2.38 %) |
Dec 14 2020 | NEO | NEOGENOMICS INC | JONES STEVEN C | Director | Sell | S | 50.30 | 20,000 | 1,006,000 | 1,050,000 | 1.1 M to 1.1 M (-1.87 %) |
Dec 11 2020 | NEO | NEOGENOMICS INC | BALLIET JENNIFER | VP and Chief Cultur ... | Option Exercise | M | 8.03 | 15,000 | 120,450 | 33,334 | |
Dec 11 2020 | NEO | NEOGENOMICS INC | BALLIET JENNIFER | VP and Chief Cultur ... | Sell | S | 49.99 | 15,000 | 749,850 | 24,980 | 40 K to 25 K (-37.52 %) |
Dec 11 2020 | NEO | NEOGENOMICS INC | BALLIET JENNIFER | VP and Chief Cultur ... | Buy | M | 8.03 | 15,000 | 120,450 | 39,980 | 25 K to 40 K (+60.05 %) |
Dec 04 2020 | NEO | NEOGENOMICS INC | Bonello William | President, Informat ... | Option Exercise | M | 8.03 | 8,000 | 64,240 | 70,370 | |
Dec 04 2020 | NEO | NEOGENOMICS INC | Bonello William | President, Informat ... | Sell | S | 46.80 | 8,000 | 374,400 | 12,060 | 20.1 K to 12.1 K (-39.88 %) |
Dec 04 2020 | NEO | NEOGENOMICS INC | Bonello William | President, Informat ... | Buy | M | 8.03 | 8,000 | 64,240 | 20,060 | 12.1 K to 20.1 K (+66.33 %) |
Nov 25 2020 | NEO | NEOGENOMICS INC | CARDOZA GEORGE | President, Pharma S ... | Option Exercise | M | 7.52 | 77,074 | 579,596 | 50,000 | |
Nov 25 2020 | NEO | NEOGENOMICS INC | CARDOZA GEORGE | President, Pharma S ... | Option Exercise | M | 7.52 | 72,926 | 548,404 | 127,074 | |
Nov 25 2020 | NEO | NEOGENOMICS INC | CARDOZA GEORGE | President, Pharma S ... | Sell | S | 45.48 | 77,074 | 3,505,326 | 370,902 | 448 K to 370.9 K (-17.20 %) |
Nov 25 2020 | NEO | NEOGENOMICS INC | CARDOZA GEORGE | President, Pharma S ... | Buy | M | 7.52 | 77,074 | 579,596 | 447,976 | 370.9 K to 448 K (+20.78 %) |
Nov 25 2020 | NEO | NEOGENOMICS INC | CARDOZA GEORGE | President, Pharma S ... | Sell | S | 45.19 | 52,926 | 2,391,726 | 370,902 | 423.8 K to 370.9 K (-12.49 %) |
Nov 25 2020 | NEO | NEOGENOMICS INC | CARDOZA GEORGE | President, Pharma S ... | Buy | M | 7.52 | 72,926 | 548,404 | 423,828 | 350.9 K to 423.8 K (+20.78 %) |
Nov 16 2020 | NEO | NEOGENOMICS INC | VAN OORT DOUGLAS M | Chairman and CEO | Option Exercise | M | 7.52 | 20,000 | 150,400 | 0 | |
Nov 16 2020 | NEO | NEOGENOMICS INC | VAN OORT DOUGLAS M | Chairman and CEO | Option Exercise | M | 7.52 | 20,000 | 150,400 | 0 | |
Nov 16 2020 | NEO | NEOGENOMICS INC | VAN OORT DOUGLAS M | Chairman and CEO | Option Exercise | M | 7.52 | 358,752 | 2,697,815 | 20,000 | |
Nov 16 2020 | NEO | NEOGENOMICS INC | VAN OORT DOUGLAS M | Chairman and CEO | Option Exercise | M | 7.52 | 358,752 | 2,697,815 | 20,000 | |
Nov 16 2020 | NEO | NEOGENOMICS INC | VAN OORT DOUGLAS M | Chairman and CEO | Option Exercise | M | 7.52 | 121,248 | 911,785 | 378,752 | |
Nov 16 2020 | NEO | NEOGENOMICS INC | VAN OORT DOUGLAS M | Chairman and CEO | Option Exercise | M | 7.52 | 121,248 | 911,785 | 378,752 | |
Nov 16 2020 | NEO | NEOGENOMICS INC | VAN OORT DOUGLAS M | Chairman and CEO | Sell | S | 42.34 | 100,000 | 4,234,000 | 2,422,790 | 2.5 M to 2.4 M (-3.96 %) |
Nov 16 2020 | NEO | NEOGENOMICS INC | VAN OORT DOUGLAS M | Chairman and CEO | Sell | S | 42.34 | 100,000 | 4,234,000 | 2,422,790 | 2.5 M to 2.4 M (-3.96 %) |
Nov 16 2020 | NEO | NEOGENOMICS INC | VAN OORT DOUGLAS M | Chairman and CEO | Buy | M | 7.52 | 20,000 | 150,400 | 2,522,790 | 2.5 M to 2.5 M (+0.80 %) |
Nov 16 2020 | NEO | NEOGENOMICS INC | VAN OORT DOUGLAS M | Chairman and CEO | Buy | M | 7.52 | 20,000 | 150,400 | 2,522,790 | 2.5 M to 2.5 M (+0.80 %) |
Nov 16 2020 | NEO | NEOGENOMICS INC | VAN OORT DOUGLAS M | Chairman and CEO | Sell | S | 41.56 | 118,752 | 4,935,333 | 2,502,790 | 2.6 M to 2.5 M (-4.53 %) |
Nov 16 2020 | NEO | NEOGENOMICS INC | VAN OORT DOUGLAS M | Chairman and CEO | Sell | S | 41.56 | 118,752 | 4,935,333 | 2,502,790 | 2.6 M to 2.5 M (-4.53 %) |
Nov 16 2020 | NEO | NEOGENOMICS INC | VAN OORT DOUGLAS M | Chairman and CEO | Buy | M | 7.52 | 358,752 | 2,697,815 | 2,621,542 | 2.3 M to 2.6 M (+15.85 %) |
Nov 16 2020 | NEO | NEOGENOMICS INC | VAN OORT DOUGLAS M | Chairman and CEO | Buy | M | 7.52 | 358,752 | 2,697,815 | 2,621,542 | 2.3 M to 2.6 M (+15.85 %) |
Nov 16 2020 | NEO | NEOGENOMICS INC | VAN OORT DOUGLAS M | Chairman and CEO | Sell | S | 42.18 | 121,248 | 5,114,241 | 2,262,790 | 2.4 M to 2.3 M (-5.09 %) |
Nov 16 2020 | NEO | NEOGENOMICS INC | VAN OORT DOUGLAS M | Chairman and CEO | Sell | S | 42.18 | 121,248 | 5,114,241 | 2,262,790 | 2.4 M to 2.3 M (-5.09 %) |
Nov 16 2020 | NEO | NEOGENOMICS INC | VAN OORT DOUGLAS M | Chairman and CEO | Buy | M | 7.52 | 121,248 | 911,785 | 2,384,038 | 2.3 M to 2.4 M (+5.36 %) |
Nov 16 2020 | NEO | NEOGENOMICS INC | VAN OORT DOUGLAS M | Chairman and CEO | Buy | M | 7.52 | 121,248 | 911,785 | 2,384,038 | 2.3 M to 2.4 M (+5.36 %) |
Nov 12 2020 | NEO | NEOGENOMICS INC | Pedulla Denise E | General Counsel | Option Exercise | M | 7.85 | 15,000 | 117,750 | 0 | |
Nov 12 2020 | NEO | NEOGENOMICS INC | Pedulla Denise E | General Counsel | Sell | S | 42.00 | 2,262 | 95,004 | 56,726 | 59 K to 56.7 K (-3.83 %) |
Nov 12 2020 | NEO | NEOGENOMICS INC | Pedulla Denise E | General Counsel | Buy | M | 7.85 | 15,000 | 117,750 | 58,988 | 44 K to 59 K (+34.10 %) |
Sep 30 2020 | NEO | NEOGENOMICS INC | JONES STEVEN C | Director | Gift | G | 0.00 | 25,000 | 0 | 72,932 | 97.9 K to 72.9 K (-25.53 %) |
Sep 30 2020 | NEO | NEOGENOMICS INC | JONES STEVEN C | Director | Sell | S | 36.55 | 81,000 | 2,960,550 | 97,932 | 178.9 K to 97.9 K (-45.27 %) |
Sep 30 2020 | NEO | NEOGENOMICS INC | JONES STEVEN C | Director | Sell | S | 36.56 | 19,000 | 694,640 | 178,932 | 197.9 K to 178.9 K (-9.60 %) |
Sep 30 2020 | NEO | NEOGENOMICS INC | JONES STEVEN C | Director | Sell | S | 36.95 | 141,049 | 5,211,761 | 1,200,000 | 1.3 M to 1.2 M (-10.52 %) |
Sep 30 2020 | NEO | NEOGENOMICS INC | JONES STEVEN C | Director | Sell | S | 36.34 | 38,951 | 1,415,479 | 1,341,049 | 1.4 M to 1.3 M (-2.82 %) |
Sep 24 2020 | NEO | NEOGENOMICS INC | CROWTHER BRUCE K | Director | Option Exercise | M | 9.11 | 8,333 | 75,914 | 0 | |
Sep 24 2020 | NEO | NEOGENOMICS INC | CROWTHER BRUCE K | Director | Sell | S | 35.01 | 8,333 | 291,738 | 46,483 | 54.8 K to 46.5 K (-15.20 %) |
Sep 24 2020 | NEO | NEOGENOMICS INC | CROWTHER BRUCE K | Director | Buy | M | 9.11 | 8,333 | 75,914 | 54,816 | 46.5 K to 54.8 K (+17.93 %) |
Sep 24 2020 | NEO | NEOGENOMICS INC | CROWTHER BRUCE K | Director | Sell | S | 35.68 | 2,400 | 85,632 | 46,483 | 48.9 K to 46.5 K (-4.91 %) |
Sep 10 2020 | NEO | NEOGENOMICS INC | JONES STEVEN C | Director | Sell | S | 37.13 | 37,991 | 1,410,606 | 1,380,000 | 1.4 M to 1.4 M (-2.68 %) |
Sep 10 2020 | NEO | NEOGENOMICS INC | JONES STEVEN C | Director | Sell | S | 36.98 | 71,583 | 2,647,139 | 1,417,991 | 1.5 M to 1.4 M (-4.81 %) |
Sep 10 2020 | NEO | NEOGENOMICS INC | JONES STEVEN C | Director | Sell | S | 36.13 | 10,426 | 376,691 | 1,489,574 | 1.5 M to 1.5 M (-0.70 %) |
Aug 13 2020 | NEO | NEOGENOMICS INC | VAN OORT DOUGLAS M | Chairman and CEO | Gift | G | 0.00 | 10,000 | 0 | 2,262,790 | 2.3 M to 2.3 M (-0.44 %) |
Aug 13 2020 | NEO | NEOGENOMICS INC | VAN OORT DOUGLAS M | Chairman and CEO | Gift | G | 0.00 | 5,000 | 0 | 15,000 | 10 K to 15 K (+50.00 %) |
Aug 13 2020 | NEO | NEOGENOMICS INC | VAN OORT DOUGLAS M | Chairman and CEO | Gift | G | 0.00 | 5,000 | 0 | 2,272,790 | 2.3 M to 2.3 M (-0.22 %) |
Aug 13 2020 | NEO | NEOGENOMICS INC | VAN OORT DOUGLAS M | Chairman and CEO | Gift | G | 0.00 | 10,000 | 0 | 2,277,790 | 2.3 M to 2.3 M (-0.44 %) |
Aug 10 2020 | NEO | NEOGENOMICS INC | HANNAH ALISON L. | Director | Option Exercise | M | 7.27 | 10,000 | 72,700 | 0 | |
Aug 10 2020 | NEO | NEOGENOMICS INC | HANNAH ALISON L. | Director | Buy | M | 7.27 | 10,000 | 72,700 | 88,796 | 78.8 K to 88.8 K (+12.69 %) |
Aug 10 2020 | NEO | NEOGENOMICS INC | CARDOZA GEORGE | President, Pharma S ... | Option Exercise | M | 7.15 | 100,000 | 715,000 | 0 | |
Aug 10 2020 | NEO | NEOGENOMICS INC | CARDOZA GEORGE | President, Pharma S ... | Sell | S | 39.35 | 82,500 | 3,246,375 | 350,902 | 433.4 K to 350.9 K (-19.04 %) |
Aug 10 2020 | NEO | NEOGENOMICS INC | CARDOZA GEORGE | President, Pharma S ... | Buy | M | 7.15 | 100,000 | 715,000 | 433,402 | 333.4 K to 433.4 K (+29.99 %) |
Aug 04 2020 | NEO | NEOGENOMICS INC | Bonello William | President, Informat ... | Option Exercise | M | 8.03 | 1,964 | 15,771 | 78,370 | |
Aug 04 2020 | NEO | NEOGENOMICS INC | Bonello William | President, Informat ... | Option Exercise | M | 7.52 | 20,036 | 150,671 | 35,727 | |
Aug 04 2020 | NEO | NEOGENOMICS INC | Bonello William | President, Informat ... | Sell | S | 38.61 | 22,000 | 849,420 | 12,060 | 34.1 K to 12.1 K (-64.59 %) |
Aug 04 2020 | NEO | NEOGENOMICS INC | Bonello William | President, Informat ... | Buy | M | 8.03 | 1,964 | 15,771 | 34,060 | 32.1 K to 34.1 K (+6.12 %) |
Aug 04 2020 | NEO | NEOGENOMICS INC | Bonello William | President, Informat ... | Buy | M | 7.52 | 20,036 | 150,671 | 32,096 | 12.1 K to 32.1 K (+166.14 %) |
Aug 04 2020 | NEO | NEOGENOMICS INC | BALLIET JENNIFER | VP and Chief Cultur ... | Option Exercise | M | 7.52 | 13,000 | 97,760 | 7,000 | |
Aug 04 2020 | NEO | NEOGENOMICS INC | BALLIET JENNIFER | VP and Chief Cultur ... | Sell | S | 39.25 | 13,000 | 510,250 | 24,980 | 38 K to 25 K (-34.23 %) |
Aug 04 2020 | NEO | NEOGENOMICS INC | BALLIET JENNIFER | VP and Chief Cultur ... | Buy | M | 7.52 | 13,000 | 97,760 | 37,980 | 25 K to 38 K (+52.04 %) |
Aug 04 2020 | NEO | NEOGENOMICS INC | VAN OORT DOUGLAS M | Chairman and CEO | Payment of Exercise | F | 0.00 | 5,953 | 0 | 2,287,790 | 2.3 M to 2.3 M (-0.26 %) |
Aug 03 2020 | NEO | NEOGENOMICS INC | SHOVLIN ROBERT J. | President, Clinical ... | Option Exercise | M | 19.60 | 16,724 | 327,790 | 50,173 | |
Aug 03 2020 | NEO | NEOGENOMICS INC | SHOVLIN ROBERT J. | President, Clinical ... | Option Exercise | M | 7.52 | 66,667 | 501,336 | 0 | |
Aug 03 2020 | NEO | NEOGENOMICS INC | SHOVLIN ROBERT J. | President, Clinical ... | Sell | S | 38.17 | 81,356 | 3,105,359 | 148,270 | 229.6 K to 148.3 K (-35.43 %) |
Aug 03 2020 | NEO | NEOGENOMICS INC | SHOVLIN ROBERT J. | President, Clinical ... | Buy | M | 19.60 | 16,724 | 327,790 | 229,626 | 212.9 K to 229.6 K (+7.86 %) |
Aug 03 2020 | NEO | NEOGENOMICS INC | SHOVLIN ROBERT J. | President, Clinical ... | Buy | M | 7.52 | 66,667 | 501,336 | 212,902 | 146.2 K to 212.9 K (+45.59 %) |
Aug 03 2020 | NEO | NEOGENOMICS INC | Kelly Michael Aaron | Director | Option Exercise | A | 37.53 | 2,223 | 83,429 | 2,223 | |
Aug 03 2020 | NEO | NEOGENOMICS INC | Kelly Michael Aaron | Director | Grant | A | 0.00 | 1,782 | 0 | 1,782 | 0 to 1.8 K |
Jun 23 2020 | NEO | NEOGENOMICS INC | Dieter Cynthia J | Chief Accounting Of ... | Option Exercise | A | 28.35 | 3,968 | 112,493 | 3,968 | |
Jun 23 2020 | NEO | NEOGENOMICS INC | Dieter Cynthia J | Chief Accounting Of ... | Grant | A | 0.00 | 605 | 0 | 605 | 0 to 605 |
Jun 04 2020 | NEO | NEOGENOMICS INC | Stahler Rachel A | Director | Option Exercise | A | 28.54 | 3,448 | 98,406 | 3,448 | |
Jun 04 2020 | NEO | NEOGENOMICS INC | Stahler Rachel A | Director | Grant | A | 0.00 | 2,698 | 0 | 2,698 | 0 to 2.7 K |
Jun 01 2020 | NEO | NEOGENOMICS INC | HANNAH ALISON L. | Director | Option Exercise | A | 28.54 | 3,448 | 98,406 | 3,448 | |
Jun 01 2020 | NEO | NEOGENOMICS INC | HANNAH ALISON L. | Director | Grant | A | 0.00 | 2,698 | 0 | 78,796 | 76.1 K to 78.8 K (+3.55 %) |
Jun 01 2020 | NEO | NEOGENOMICS INC | KANOVSKY STEPHEN M | Director | Option Exercise | A | 28.54 | 3,448 | 98,406 | 3,448 | |
Jun 01 2020 | NEO | NEOGENOMICS INC | KANOVSKY STEPHEN M | Director | Grant | A | 0.00 | 2,698 | 0 | 6,117 | 3.4 K to 6.1 K (+78.91 %) |
Jun 01 2020 | NEO | NEOGENOMICS INC | TETRAULT LYNN A. | Director | Option Exercise | A | 28.54 | 3,448 | 98,406 | 3,448 | |
Jun 01 2020 | NEO | NEOGENOMICS INC | TETRAULT LYNN A. | Director | Grant | A | 0.00 | 2,698 | 0 | 44,351 | 41.7 K to 44.4 K (+6.48 %) |
Jun 01 2020 | NEO | NEOGENOMICS INC | HIPP RAYMOND R | Director | Option Exercise | A | 28.54 | 3,448 | 98,406 | 3,448 |